# clm_4145313CD790

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: total_equity  
value: 143,486,000,000 DKK  
valid_from: 2024-12-31  
valid_to: 2025-12-31  
published: 2025-02-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_51EBABE50856  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk total equity: 143,486,000,000 DKK", as of 2024-12-31 (until 2025-12-31). Claim clm_4145313CD790, https://asof.is/claim/clm_4145313CD790, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:Equity in 20-F FY2024, filed 2025-02-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm (primary, SEC EDGAR 20-F FY2024, published 2025-02-05)

## Supersedes

- [Novo Nordisk](/record/novo-nordisk.md) | total_equity | 106,561,000,000 DKK | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_4145313CD790](/claim/clm_4145313CD790.md) | [clm_A40D8D2F280A](/claim/clm_A40D8D2F280A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.